See also this year's filing and all EDGAR filings for this company.
PDF Report 0000894158_2020_Theriva_Biologics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.00679997694923068, 'aggregate_val': 17235000, 'exp_sum': 17353000, 'exp_to_value': {'AssetsCurrent': 16426000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 367000, 'remainder_Assets': 560000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000894158')"} |
Graph
Absolute values for 0000894158, Theriva Biologics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,426,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 367,000 |
| 3 | remainder_Assets | 442,000 |
| 4 | LiabilitiesCurrent | 5,275,000 |
| 5 | LiabilitiesNoncurrent | 473,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,580,000 |
| 9 | ResearchAndDevelopmentExpense | 11,083,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 283,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,235,000 |
| 1 | Liabilities | 5,748,000 |
| 2 | Expenses | 15,663,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 11,487,000 |
| 5 | NetIncome | -15,380,000 |
| 6 | ComprehensiveNetIncome | -15,380,000 |
| 7 | BaseVar | 19,464,500 |
| 8 | EconomicCapitalRatio | 0.381 |